Literature DB >> 11257102

The Rb/E2F pathway and cancer.

J R Nevins1.   

Abstract

Over the past decade, studies focusing on the mechanisms controlling cellular proliferation have converged with equally intensive efforts directed at the analysis of oncogenic pathways associated with human cancer. These convergent studies have revealed the central role played by the pathway that controls the activity of the retinoblastoma tumor suppressor protein (Rb), which in turn regulates the E2F transcription factor. In particular, it is now clear that the Rb/E2F pathway is critical in regulating the initiation of DNA replication. It is also clear that the control of the pathway is disrupted in virtually all human cancers. Questions remain, however, as to the specific role played by individual activities within the pathway in the control of cell growth and their participation in the development of cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257102     DOI: 10.1093/hmg/10.7.699

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  320 in total

1.  E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.

Authors:  J W Zhu; S J Field; L Gore; M Thompson; H Yang; Y Fujiwara; R D Cardiff; M Greenberg; S H Orkin; J DeGregori
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Gene expression changes in response to E2F1 activation.

Authors:  Jens Stanelle; Thorsten Stiewe; Carmen C Theseling; Martin Peter; Brigitte M Pützer
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

3.  NPAT expression is regulated by E2F and is essential for cell cycle progression.

Authors:  Guang Gao; Adrian P Bracken; Karina Burkard; Diego Pasini; Marie Classon; Claire Attwooll; Masashi Sagara; Takashi Imai; Kristian Helin; Jiyong Zhao
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex/cyclosome.

Authors:  Somsubhra Nath; Abhishek Chowdhury; Sanjib Dey; Anirban Roychoudhury; Abira Ganguly; Dibyendu Bhattacharyya; Susanta Roychoudhury
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

5.  Human Extrafollicular CD4+ Th Cells Help Memory B Cells Produce Igs.

Authors:  Sang Taek Kim; Jin-Young Choi; Begona Lainez; Vincent P Schulz; David E Karas; Eric D Baum; Jennifer Setlur; Patrick G Gallagher; Joe Craft
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

6.  Distinct mechanisms of E2F regulation by Drosophila RBF1 and RBF2.

Authors:  Olivier Stevaux; Dessislava Dimova; Maxim V Frolov; Barbie Taylor-Harding; Erick Morris; Nicholas Dyson
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

7.  CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P.

Authors:  Partha Mitra; Prachi N Ghule; Margaretha van der Deen; Ricardo Medina; Rong-Lin Xie; William F Holmes; Xin Ye; Keiichi I Nakayama; J Wade Harper; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

8.  Integrative analysis of many RNA-seq datasets to study alternative splicing.

Authors:  Wenyuan Li; Chao Dai; Shuli Kang; Xianghong Jasmine Zhou
Journal:  Methods       Date:  2014-02-28       Impact factor: 3.608

9.  Synthetic lethality of retinoblastoma mutant cells in the Drosophila eye by mutation of a novel peptidyl prolyl isomerase gene.

Authors:  Kyle A Edgar; Marcia Belvin; Annette L Parks; Kellie Whittaker; Matt B Mahoney; Monique Nicoll; Christopher C Park; Christopher G Winter; Feng Chen; Kim Lickteig; Ferhad Ahmad; Hanife Esengil; Matthew V Lorenzi; Amanda Norton; Brent A Rupnow; Laleh Shayesteh; Mariano Tabios; Lynn M Young; Pamela M Carroll; Casey Kopczynski; Gregory D Plowman; Lori S Friedman; Helen L Francis-Lang
Journal:  Genetics       Date:  2005-03-02       Impact factor: 4.562

10.  Increased levels and activity of E2F1 transcription factor in myelodysplastic bone marrow.

Authors:  Gurveen Saberwal; Steven Lucas; Imke Janssen; Avnish Deobhakta; Wen-Yang Hu; Naomi Galili; Azra Raza; Suneel D Mundle
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.